More News

08 May 2018 Atara Biotherapeutics Expands T-Cell Immunotherapy Collaboration to Advance Next-Generation CAR T Technologies in Oncology, Autoimmune and Other Diseases
08 May 2018 Proposed Acquisition of Shire plc by Takeda
07 May 2018 Aptose Exercises Early Option for CG-806 License From CrystalGenomics
07 May 2018 LipimetiX Development Announces Sub-License of Apo E Mimetic Peptide Platform to Anji Pharma, China
04 May 2018 Sarepta Therapeutics Announces Partnership with Myonexus Therapeutics for the Advancement of Multiple Gene Therapy Programs Aimed at Treating Distinct Forms of Limb-Girdle Muscular Dystrophies
04 May 2018 Exelixis and Invenra Enter Into Collaboration to Discover and Develop Novel Biologics to Treat Cancer
04 May 2018 Moderna and Merck Expand mRNA Cancer Vaccines Collaboration
03 May 2018 Third Rock Ventures Launches Casma Therapeutics with $58.5 Million Investment to Harness the Cellular Process of Autophagy to Develop Breakthrough Therapies
03 May 2018 Ferring Signs Global Agreement to Commercialise Novel Gene Therapy for Bladder Cancer Patients
02 May 2018 Bactevo Enters Drug Discovery Agreement with Boehringer Ingelheim
02 May 2018 Janssen to Acquire BeneVir Biopharm to Advance Immunotherapy Regimens
02 May 2018 Merck KGaA, Darmstadt, Germany to Develop Abituzumab in Metastatic Colorectal Cancer with SFJ Pharmaceuticals Group
01 May 2018 Biogen and Neurimmune Announce Option Exercise for Alzheimer’s Disease Investigational Treatment Aducanumab
30 Apr 2018 4DMT and ROCHE Expand Ophthalmology Partnership to Develop and Commercialize Multiple AAV Gene Therapy Products
30 Apr 2018 WuXi Biologics to Invest €325 Million to Build Largest Biomanufacturing Facility Using Single-Use Bioreactors in Ireland
25 Apr 2018 Boehringer Ingelheim R&D Pushes to Transcend Disease Boundaries
25 Apr 2018 Entasis Therapeutics and Zai Lab Announce Exclusive License Agreement in Asia-Pacific and Global Strategic Development Collaboration for ETX2514
24 Apr 2018 Zymeworks and Celgene Expand Bispecific Antibody Collaboration
23 Apr 2018 CBT Pharmaceuticals and CrystalGenomics Announce Partnership for Co-development of Global Immuno-Oncology Therapy
23 Apr 2018 EpimAb Biotherapeutics and Zhejiang Teruisi Biopharmaceutical Announce Development Collaboration on Epimab’s FIT012 Bispecific Antibody Program
22 Apr 2018 Biogen and Ionis Expand Strategic Collaboration to Develop Drug Candidates for a Broad Range of Neurological Diseases
20 Apr 2018 UCB to expand epilepsy portfolio with strategic acquisition of Midazolam Nasal Spray from Proximagen
17 Apr 2018 Basilea licenses late-stage oncology drug candidate derazantinib from ArQule
17 Apr 2018 Cardurion Pharmaceuticals Licenses Clinical Stage Heart Failure Candidate from Astellas
17 Apr 2018 Bristol-Myers Squibb Announces Worldwide Collaboration with Janssen to Develop and Commercialize Next-Generation Cardiovascular Therapy

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up